Bitcoin’s Potential Role in Navigating Biotech Winter, Says Biopharma Executive
Atai Life Sciences, a biopharmaceutical company listed on NASDAQ, believes cryptocurrencies like Bitcoin could help biotech startups survive the long and costly regulatory approval process. The firm plans to invest $5 million in Bitcoin as a hedge against inflation and diversifying its assets, according to founder Christian Angermayer. As the biotech industry faces financial challenges, ...
